PRN Medication Options for Breakthrough Anxiety or Panic Attacks (Non-Benzodiazepine)
For breakthrough anxiety or panic attacks when benzodiazepines are not an option, hydroxyzine (25-50 mg PRN) is the most practical first-line choice, followed by propranolol (10-40 mg PRN) or atenolol (25-50 mg PRN) for somatic anxiety symptoms, with low-dose quetiapine (25-50 mg PRN) reserved as a third-line option despite limited PRN-specific evidence.
Algorithmic Approach to PRN Non-Benzodiazepine Selection
First-Line: Hydroxyzine
- Dosing: 25-50 mg orally PRN, up to 3-4 times daily 1
- Onset: 15-30 minutes
- Best for: Generalized anxiety symptoms, patients with substance use concerns, those requiring non-controlled substances
- Cautions: Sedation, anticholinergic effects (dry mouth, confusion in elderly), QTc prolongation at higher doses
- Advantage: FDA-approved for anxiety, non-addictive, rapid onset
Second-Line: Beta-Blockers
Propranolol (traditional choice):
- Dosing: 10-40 mg PRN, 30-60 minutes before anticipated anxiety-provoking situations 2
- Best for: Performance anxiety, panic attacks with prominent somatic symptoms (palpitations, tremor, sweating)
- Cautions: Avoid in asthma, bradycardia, hypotension, heart block
- Evidence: Established use for panic disorder and performance anxiety 2
Atenolol (emerging alternative):
- Dosing: 25-50 mg PRN
- Best for: Same indications as propranolol but may be better tolerated
- Evidence: Preliminary data shows 86% of patients reported positive effects for anxiety symptoms, with 100% of patients who tried both preferring atenolol over propranolol 3
- Advantage: Longer half-life allows once-daily dosing, cardioselective (safer in mild reactive airway disease)
Third-Line: Low-Dose Atypical Antipsychotics
Quetiapine:
- Dosing: 25-50 mg PRN (significantly lower than typical antipsychotic dosing) 4, 5
- Best for: Severe breakthrough anxiety unresponsive to above options, patients with comorbid agitation
- Cautions: Sedation, metabolic effects with chronic use, extrapyramidal symptoms (rare at low doses), monitor for diabetes/weight gain
- Evidence: Supported for generalized anxiety disorder 5, used PRN for breakthrough nausea/agitation in other contexts 4
- Important caveat: Most evidence is for scheduled dosing, not PRN use; reserve for refractory cases
Olanzapine:
- Dosing: 2.5-5 mg PRN 4, 6
- Best for: Acute severe agitation with anxiety (particularly in elderly or medically complex patients)
- Cautions: Similar to quetiapine; do NOT combine with parenteral benzodiazepines within 2 hours due to respiratory depression risk 6
Alternative Considerations
Antihistamines (Beyond Hydroxyzine)
- Diphenhydramine: 25-50 mg PRN, but more sedating and anticholinergic than hydroxyzine; not recommended as first choice 1
Buspirone
- NOT recommended for PRN use: Requires 2-4 weeks of regular dosing to become effective 1, 5
- Only effective with chronic scheduled administration
Gabapentin/Pregabalin
- Limited PRN evidence: Primarily studied for scheduled dosing in generalized anxiety disorder 5, 7
- Gabapentin: May help anxiety-related insomnia when dosed at bedtime 8
- Concern: Increasing misuse potential; requires careful patient selection 8
Critical Clinical Pitfalls
Avoid antihistamine/analgesic OTC combinations for chronic anxiety management—lack efficacy and safety data 9
Do not use barbiturates or chloral hydrate—outdated, dangerous, not recommended 1
Paradoxical reactions: Approximately 10% of patients experience paradoxical agitation with benzodiazepines 1; this can also rarely occur with antihistamines
Elderly patients: Start with half doses of any agent; hydroxyzine and beta-blockers require particular caution due to anticholinergic effects and orthostatic hypotension respectively 6
Tolerance development: Even non-benzodiazepine PRN medications can lead to psychological dependence on "rescue" medications; integrate with cognitive-behavioral therapy when possible 10
Beta-blocker contraindications: Screen for asthma, COPD, heart block, bradycardia, and hypotension before prescribing 2
Monitoring and Follow-Up
Reassess within 2-4 weeks of initiating any PRN medication to evaluate:
PRN medications are temporizing measures: Most patients with recurrent panic attacks or breakthrough anxiety require scheduled maintenance pharmacotherapy (SSRIs/SNRIs as first-line) combined with cognitive-behavioral therapy 7, 12, 13
Document specific indications for PRN use and review daily in acute settings 6